A0232-5MG Display Image

Alfuzosin hydrochloride, >=98% (HPLC), solid

Code: A0232-5MG D2-231

Biochem/physiol Actions

Alfuzosin hydrochloride is an alpha-adrenergic blocker used to treat benign prostatic hyperplasia (BPH). It works by relaxing the muscles in the prost...


read more

Your Price
€154.25 5MG
REQUEST

Biochem/physiol Actions

Alfuzosin hydrochloride is an alpha-adrenergic blocker used to treat benign prostatic hyperplasia (BPH). It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate.

Features and Benefits

This compound is featured on the α1-Adrenoceptors and α2-Adrenoceptors pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

5, 25 mg in glass bottle

assay≥98% (HPLC)
formsolid
Gene Informationhuman ... ADRA1A(148), ADRA1B(147), ADRA1D(146)
InChI keyYTNKWDJILNVLGX-UHFFFAOYSA-N
InChI1S/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23);1H
originatorSanofi Aventis
Quality Level100
SMILES stringCl.COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C3CCCO3
solubilityDMSO: >10 mg/mL, H2O: insoluble
Cas Number81403-68-1
This product has met the following criteria: